Welcome to our dedicated page for Medical Care Technologies news (Ticker: MDCE), a resource for investors and traders seeking the latest updates and insights on Medical Care Technologies stock.
Medical Care Technologies Inc. develops and commercializes artificial intelligence applications across consumer software, imaging analysis, healthcare-oriented pre-screening and collectibles authentication. News about MDCE centers on its AI technology stack, including Snapshot Recipes, a mobile recipe application with AI-generated food and beverage content, and Real Game Used, a subsidiary developing a patent-pending AI authentication platform for sports memorabilia.
Company updates also cover AI imaging initiatives for dermatological analysis, wellness monitoring, product verification and automated quality control, as well as capital and asset-monetization activity through Infinite Auctions. Recurring announcements describe product redesigns, commercialization pathways, subsidiary activity, mobile-app user growth initiatives, and enterprise API or visual analytics use cases.
Medical Care Technologies (OTC PINK:MDCE) announced it was approved as an Apple Developer on October 24, 2025, enabling the company to create, test, and distribute iOS apps worldwide.
The company said its first AI-based mobile application (Name Pending Trademark) is in final development and is planned for release in Q4 2025. Management framed the approval as a key step to expand digital health and AI offerings to iPhone and iPad users.
Medical Care Technologies (OTC PINK:MDCE) said it is positioning its proprietary AI ecosystem to serve clinical diagnostics, consumer health, fitness, nutrition and digital authentication markets collectively valued at $700 billion by 2030. The company describes an AI infrastructure designed to continuously learn, adapt and expand into new verticals without system reinvention, enabling multiple monetization paths such as recurring revenue, licensing and technology integrations.
Management highlighted cross-market scalability and said additional announcements and product rollout details will be released in the coming weeks.
Medical Care Technologies (OTC PINK: MDCE) announced on October 16, 2025 a strategic move into consumer AI mobile applications aimed at generating earlier-than-anticipated revenue by diversifying from subsidiary-only income into multiple app offerings.
The company cites addressable markets including the global wellness app sector (over $140 billion annually) and the sports collectibles and authentication market (exceeding $33 billion), and says its subsidiaries Infinite Auctions and Real Game Used provide an existing operating presence in adjacent markets.
Medical Care Technologies (OTC PINK:MDCE) announced a new suite of AI-powered consumer apps for diet, fitness, and preventive health, with the first public app targeted before year-end 2025 and a flagship medical-grade AI platform scheduled for 2026.
The company said it will leverage its existing AI framework to pursue market share in the digital health space, which is noted to be projected from a 2024 value of over $140 billion to $400 billion by 2032. Management described the plan as bridging research-grade AI to mass-market accessibility while creating early revenue potential.
Medical Care Technologies (OTC PINK: MDCE) announced on October 14, 2025 that its patent-pending artificial intelligence platform—originally built for medical diagnostics—has shown adaptability across multiple industries including personal health tracking, fitness analytics, diet optimization, and wellness management.
The release cites market context: the AI-in-Healthcare market projected to exceed $208 billion by 2030 and the global fitness and wellness technology market exceeding $450 billion, positioning the technology for cross-vertical revenue opportunities. The company highlighted scalability for both professional diagnostics and consumer wellness applications.
Medical Care Technologies (OTC Pink: MDCE) on October 13, 2025 announced that its wholly owned subsidiary, Infinite Auctions LLC, will launch a Fall Flash Auction featuring authenticated game-worn memorabilia and rare sports cards from athletes including Michael Jordan, LeBron James, Tom Brady, and Lamar Jackson.
The company said Infinite Auctions is accepting consignments via www.InfiniteAuctions.com or its campaign email ahead of the submission deadline. MDCE described the auction as part of its diversification strategy while it continues AI research in medical imaging, dermatology, wound care, and micro-expression analysis to support early disease detection and mental-health evaluation.
Medical Care Technologies (OTC PINK:MDCE) on October 10, 2025 emphasized that artificial intelligence is accelerating medical research while requiring certified clinical data, medical expertise, and regulatory alignment to be trustworthy.
MDCE described a multi-vertical AI platform covering skin cancer screening, ocular imaging, wound monitoring, and behavioral health analysis, built from ethically sourced, medically validated datasets and designed to augment—not replace—clinical judgment. The company said partnerships with medical professionals, imaging specialists, and compliant data repositories remain central to its roadmap as it aims to shorten innovation cycles while preserving safety, fairness, and clinical relevance.
Medical Care Technologies (OTC PINK:MDCE) on October 9, 2025 highlighted progress in its AI preventive health platform across four verticals: skin health, ocular health, wound monitoring, and mental & behavioral health. The company tied each module to global burden statistics: 60,000+ annual deaths from melanoma and other skin cancers, 100M+ people with vision loss risk from diabetic/vascular eye disease, 5M+ chronic wound/post-surgical infection cases annually, and 700,000+ annual suicide deaths. The release described AI-assisted imaging for earlier detection and a non-clinical emotion-tracking tool for self-monitoring, and reiterated forward-looking risks to development, regulatory and operational outcomes.
CEO emphasized that AI is intended to help reveal early signs but not replace clinicians.
Medical Care Technologies (OTC PINK:MDCE) announced on October 8, 2025 that it is beginning preparatory, internal non-clinical research on two consumer AI modules: the Mental Health & Micro-Expression Tracker and the Preventive Health & Facial Biometrics Analyzer. The studies will be self-conducted by MDCE's Consumer AI Division to test algorithmic performance, consistency, and data reliability in real-world conditions.
The Tracker uses facial landmarking and emotion-recognition networks to monitor subtle stress and focus shifts; the Biometrics Analyzer uses colorimetric and vascular mapping to evaluate visible wellness indicators. Results are intended for internal model refinement and to support future wellness-research collaborations. The company emphasized accuracy, transparency, and that these tools are for self-monitoring rather than clinical diagnosis.
Medical Care Technologies (OTC Pink: MDCE) on October 7, 2025 announced a strategic split of its AI health platform into two divisions: a Clinical AI Division targeting FDA-eligible modules and formal validation, and a Consumer AI Division for general wellness and research apps.
The Clinical Division lists dermatological screening, ocular/retinal analytics, and wound monitoring as modules intended for regulatory pathways such as FDA 510(k) or De Novo, with planned validation studies and pre-submission work in upcoming quarters. The Consumer Division will deliver non-diagnostic wellness tools like mental health trackers and lifestyle scoring for apps and research partnerships.